Top Stories

Health insurers Aetna Inc. and Humana Inc. Friday said they have entered into a definitive agreement, under which Aetna would acquire Humana for a combination of cash and stock valued at about $230 per Humana share or $37 billion in total. The transaction is expected to be neutral to Aetna's 2016 operating earnings per share.

The services sector in China continued to expand in June, albeit at a slower pace, the latest PMI from HSBC Bank showed on Friday, with a PMI score of 51.8. That's down from 53.5 in May, although it remains above the boom-or-bust line of 50 that separates...


Vermont Sen. Bernie Sanders, I-Vt., has seen a significant jump in support in the Iowa Democratic Caucus, according to the results of a Quinnipiac University poll, although he continues to trail front-runner Hillary Clinton.


Asian stocks closed mostly lower on Friday, with weak commodity prices, tepid U.S. data and worries about the upcoming referendum in Greece weighing on the markets. Disappointing U.S. jobs data tempered expectations for a September interest-rate hike...

reid-070215.jpg Senate Minority Leader Harry Reid, D-Nev., touted Thursday's monthly jobs report as a sign of economic progress but said his Republican colleagues could be doing more to help American workers.
A new survey shows that nearly four out of ten children and teens in the United States have been exposed to violence within the last year. The new report, released in JAMA Pediatrics, relied on phone interviews conducted by researchers using The National Survey of Children's Exposure to Violence (NatSCEV). Information was obtained from 4,000 children, ages 0 to 17.
About one-quarter of adults aged 65 years and older used mobility devices—such as canes, walkers, and wheelchairs—in 2011, and about a third of these reported using multiple devices, according to the findings of a Journal of the American Geriatrics Society study. The use of such devices was not linked...
Vertex Pharmaceuticals Inc. (VRTX) said Thursday that the U.S. Food and Drug Administration has approved Orkambi, the first medicine to treat the underlying cause of cystic fibrosis in people ages 12 and older with two copies of the F508del mutation.... More
On the eve of a historic referendum on the next debt deal with creditors, the Greek electorate is absolutely divided, according to reports. Agony for the next day is prevailing clashing with hope, as Greek and foreign officials and analysts warn that...
Google's new Photo app has misidentified images of black people as gorillas. Google was alerted to the issue via Twitter by computer programmer Jacky Alcine, whose images were given the offensive tag. The company has apologized for the error and...
Follow RTT
Economic Calendar
07/03/15 9:0PMI CompositeJUN Brazil
07/03/15 9:0PMI ServicesJUN Brazil
07/03/15 7:30Official Foreign ReservesJUN 26 India
07/03/15 5:0Retail Sales (M-o-M)MAY Eurozone
07/03/15 5:0Retail Sales (Y-o-Y)MAY Eurozone
07/03/15 4:30PMI ServicesJUN UK
Complete Economic Calendar
FDA Calendar
Event DateSymbolDrug NameEvent Name
09/08/2015GEVAKanuma (BLA)FDA decision on Kanuma for the treatment of lysosomal acid lipase deficiency
09/05/2015TSROOral Rolapitant (NDA)FDA decision on oral Rolapitant for the prevention of chemotherapy-induced nausea and vomiting
09/05/2015TSROOral Rolapitant (NDA)FDA decision on Oral Rolapitant for prevention of chemotherapy-induced nausea and vomiting (C
08/27/2015AMGNEvolocumab (BLA)FDA decision on Evolocumab for the treatment of high cholesterol
08/27/2015BMYOpdivo (sBLA)FDA decision on Opdivo for expanded use in treating previously untreated patients with unresectable or metastatic melanoma.
Complete FDA Calendar